Quote:

---

Brazil trial just posted on clinicaltrials.gov: https://www.clinicaltrials.gov/ct2/show/NCT04901689

Cytodyn is moving forward under current leadership.

4 IV doses!

---

Looks like we finally have a trial setup for success!

Finally a focused trial on just Critical

4 Weeks of Dosing and All via IV Infusion sounds like we may have a real shot at approval this time.

The defining question at the moment is, How quickly can they enroll patients?

The latter of points may also be Managements company defining moment to remain seated. Keep investors happy, show significant forward progress and maybe "some" will have a shot at remaining

Coincidental posting today?? It certainly seems like Nader's attempt at firing back at the 13D. Regardless, I'll be happy when we start to actually enroll patients